Ubs Group Ag Petmed Express Inc Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Petmed Express Inc stock. As of the latest transaction made, Ubs Group Ag holds 66,219 shares of PETS stock, worth $311,229. This represents 0.0% of its overall portfolio holdings.

Number of Shares

66,219

Previous 31,946 107.28%

Holding current value

$311,229

Previous $129,000 88.37%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.94 - $4.04 $100,762 - $138,462	34,273 Added 107.28%	66,219 $243,000
Q2 2024 Aug 13, 2024	SELL	$3.95 - $4.84 $61,785 - $75,707	-15,642 Reduced 32.87%	31,946 $129,000
Q1 2024 May 13, 2024	SELL	$4.7 - $7.58 $106,943 - $172,475	-22,754 Reduced 32.35%	47,588 $227,000
Q4 2023 Feb 09, 2024	BUY	$6.89 - $11.04 $337,651 - $541,026	49,006 Added 229.69%	70,342 $531,000
Q3 2023 Nov 09, 2023	SELL	$10.21 - $14.65 $1.14 Million - $1.63 Million	-111,464 Reduced 83.93%	21,336 $218,000
Q2 2023 Aug 11, 2023	SELL	$13.68 - $16.56 $3.81 Million - $4.61 Million	-278,561 Reduced 67.72%	132,800 $1.83 Million
Q1 2023 May 12, 2023	BUY	$15.9 - $22.22 $2.29 Million - $3.2 Million	144,188 Added 53.97%	411,361 $6.68 Million
Q4 2022 Feb 08, 2023	BUY	$17.16 - $22.14 $4.35 Million - $5.61 Million	253,486 Added 1852.02%	267,173 $4.73 Million
Q3 2022 Nov 10, 2022	BUY	$19.35 - $23.52 $39,996 - $48,615	2,067 Added 17.79%	13,687 $267,000
Q2 2022 Aug 10, 2022	SELL	$19.9 - $26.13 $3.54 Million - $4.65 Million	-177,886 Reduced 93.87%	11,620 $231,000
Q1 2022 May 16, 2022	SELL	$23.62 - $29.18 $251,151 - $310,270	-10,633 Reduced 5.31%	189,506 $4.89 Million
Q4 2021 Feb 14, 2022	BUY	$25.26 - $32.0 $4.82 Million - $6.11 Million	190,825 Added 2048.8%	200,139 $5.06 Million
Q3 2021 Nov 15, 2021	SELL	$26.5 - $34.0 $12,163 - $15,606	-459 Reduced 4.7%	9,314 $250,000
Q2 2021 Aug 13, 2021	SELL	$27.73 - $46.06 $731,018 - $1.21 Million	-26,362 Reduced 72.95%	9,773 $311,000
Q1 2021 May 12, 2021	BUY	$29.77 - $51.8 $566,433 - $985,598	19,027 Added 111.22%	36,135 $1.27 Million
Q4 2020 Feb 11, 2021	SELL	$28.96 - $33.77 $372,280 - $434,113	-12,855 Reduced 42.9%	17,108 $548,000
Q3 2020 Nov 12, 2020	SELL	$29.0 - $41.83 $273,035 - $393,829	-9,415 Reduced 23.91%	29,963 $947,000
Q2 2020 Jul 31, 2020	BUY	$27.94 - $40.96 $468,553 - $686,899	16,770 Added 74.18%	39,378 $1.4 Million
Q1 2020 May 01, 2020	BUY	$22.18 - $28.78 $122,965 - $159,556	5,544 Added 32.49%	22,608 $651,000
Q4 2019 Feb 14, 2020	SELL	$17.87 - $27.37 $5.02 Million - $7.69 Million	-280,910 Reduced 94.27%	17,064 $402,000
Q3 2019 Nov 14, 2019	BUY	$15.01 - $18.47 $3.8 Million - $4.67 Million	252,918 Added 561.34%	297,974 $5.37 Million
Q2 2019 Aug 14, 2019	SELL	$15.32 - $23.65 $2.16 Million - $3.34 Million	-141,111 Reduced 75.8%	45,056 $706,000
Q1 2019 May 14, 2019	SELL	$20.5 - $24.32 $251,412 - $298,260	-12,264 Reduced 6.18%	186,167 $4.24 Million
Q4 2018 Feb 14, 2019	BUY	$22.42 - $32.67 $1.22 Million - $1.78 Million	54,583 Added 37.94%	198,431 $4.62 Million
Q3 2018 Nov 14, 2018	BUY	$33.01 - $44.57 $2.11 Million - $2.84 Million	63,787 Added 79.67%	143,848 $4.75 Million
Q2 2018 Aug 14, 2018	BUY	$33.46 - $46.17 $402,624 - $555,563	12,033 Added 17.69%	80,061 $3.53 Million
Q1 2018 May 15, 2018	BUY	$41.2 - $53.24 $1.95 Million - $2.51 Million	47,238 Added 227.22%	68,028 $2.84 Million
Q4 2017 Feb 14, 2018	BUY	$34.19 - $48.11 $44,070 - $62,013	1,289 Added 6.61%	20,790 $946,000
Q3 2017 Nov 14, 2017	BUY	$33.15 - $48.95 $73,261 - $108,179	2,210 Added 12.78%	19,501 $647,000
Q2 2017 Aug 14, 2017	SELL	N/A	-62,669 Reduced 78.38%	17,291 $702,000
Q1 2017 Nov 14, 2017	BUY	N/A	79,960	79,960 $1.61 Million

Others Institutions Holding PETS

# of Institutions

103

Shares Held

9.54M

Call Options Held

39.6K

Put Options Held

137K

View Full List

About PETMED EXPRESS INC

Ticker PETS
Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Shares Outstandng 21,013,800
Market Cap $98.8M
Description
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint c...

More about PETS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account